Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$298,166,725
+$48,783,775 QoQ
Shares Held
1,184,894
+3.3% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
1.60%
of 13F equity value
Holder Rank
#119
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 2%
None 5%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KEYBANK NATIONAL ASSOCIATION/OH holds $1,077,519,603 across 14 Drug Manufacturers - General names. ABBV ranks #2 (27.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,355,842 | $344,343,192 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
1,184,894 | $298,166,725 | |
| 3 | LLY |
ELI LILLY & Co
|
109,086 | $130,841,031 | |
| 4 | MRK |
Merck & Co., Inc.
|
847,233 | $108,869,440 | |
| 5 | AMGN |
Amgen Inc
|
241,243 | $87,358,914 | |
| 6 | PFE |
Pfizer Inc
|
1,445,780 | $34,814,381 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
500,631 | $28,846,358 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
127,699 | $16,133,491 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $298,166,725 | 1,184,894 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $249,382,950 | 1,146,641 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $240,612,993 | 1,053,057 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $241,919,474 | 1,044,828 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $195,229,732 | 1,051,771 | Shares | Defined | 2025-08-04 | |
| 2025-03-31 | $222,286,681 | 1,060,933 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $148,203,043 | 834,007 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $165,972,657 | 840,453 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $145,574,683 | 848,733 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $154,646,967 | 849,242 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $131,608,426 | 849,251 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $127,333,013 | 854,240 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $117,033,483 | 868,652 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $140,353,493 | 880,677 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $147,318,342 | 911,567 | Shares | Defined | 2023-01-31 | |
| 2022-09-30 | $123,401,263 | 919,464 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $140,967,391 | 920,393 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $151,673,195 | 935,619 | Shares | Defined | 2022-04-28 | |
| 2021-12-31 | $130,019,474 | 960,262 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $104,397,772 | 967,811 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $109,552,762 | 972,592 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $107,232,600 | 990,876 | Shares | Defined | 2021-09-03 | |
| 2020-12-31 | $107,654,140 | 1,004,705 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $89,740,159 | 1,024,548 | Shares | Defined | 2020-10-29 | |
| 2020-06-30 | $101,640,550 | 1,035,247 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $79,641,330 | 1,045,299 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||